Stephen Fawell

5PUBLICATIONS
109CO-AUTHORS
Molecular targetsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.

Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu

|Nov 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.

Anna D Staniszewska, Domenic Pilger, Sonja J Gill

|Mar 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners.

Aatman S Doshi, Susan Cantin, Marylens Hernandez

|Aug 05, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper.

Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill

Pageof 1